Entry |
|
Name |
Mutation-activated KRAS/NRAS to ERK signaling pathway
|
Definition |
(KRAS*,NRAS*) -> RAF -> MEK -> ERK -> CCND1 |
Expanded |
(3845v1,4893v1) -> (369,673,5894) -> (5604,5605) -> (5594,5595) -> 595 |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00014 | Non-small cell lung cancer |
|
Gene |
3845 | KRAS; KRAS proto-oncogene, GTPase |
4893 | NRAS; NRAS proto-oncogene, GTPase |
369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
5594 | MAPK1; mitogen-activated protein kinase 1 |
5595 | MAPK3; mitogen-activated protein kinase 3 |
|
Variant |
|
Reference |
|
Authors |
Schubbert S, Shannon K, Bollag G |
Title |
Hyperactive Ras in developmental disorders and cancer. |
Journal |
|
Reference |
|
Authors |
Adjei AA. |
Title |
Blocking oncogenic Ras signaling for cancer therapy. |
Journal |
|
Reference |
|
Authors |
Janssen KP. |
Title |
Murine models of colorectal cancer: studying the role of oncogenic K-ras. |
Journal |
|
Reference |
|
Authors |
Ryan AJ, Susil B, Jobling TW, Oehler MK. |
Title |
Endometrial cancer. |
Journal |
|
Reference |
|
Authors |
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H. |
Title |
The molecular pathogenesis of acute myeloid leukemia. |
Journal |
|
Reference |
|
Authors |
Chin L. |
Title |
The genetics of malignant melanoma: lessons from mouse and man. |
Journal |
|
LinkDB |
|